VEGF and its Receptors are Expressed in a Pediatric Angiosarcoma in a Patient with Aicardi's Syndrome
- 1 June 2000
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 114 (6) , 1209-1210
- https://doi.org/10.1046/j.1523-1747.2000.00005-3.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Tsc2+/– mice develop tumors in multiple sites that express gelsolin and are influenced by genetic backgroundJournal of Clinical Investigation, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Angiopoietins 3 and 4: Diverging gene counterparts in mice and humansProceedings of the National Academy of Sciences, 1999
- Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo AngiogenesisScience, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Angiogenesis and the skin: A primerJournal of the American Academy of Dermatology, 1996
- Aicardi syndrome, metastatic angiosarcoma of the leg, and scalp lipomaAmerican Journal of Medical Genetics, 1993
- Vascular permeability factor mRNA and protein expression in human kidneyKidney International, 1992